FDA March 19 hearing in Senate Labor Cmte. likely to include reform, budget issues.
This article was originally published in The Rose Sheet
Executive Summary
FDA "RESTRUCTURING" HEARING IN SENATE LABOR CMTE. SET FOR MARCH 19, when the Senate begins its formal consideration of FDA-related issues, including proposals to revise and restructure the operations of the agency. Although an agenda is still in the planning stage, the committee has indicated that the March hearing is likely to focus on FDA reform, reauthorization of the Prescription Drug User Fee Act (PDUFA), other user fees and FDA resources. The hearing will take place in Dirksen Senate Office Building, room SD-430, starting at 9:30 a.m.